Page last updated: 2024-12-10

n,n-dimethylepinephrine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N,N-dimethylepinephrine: quaternary analog of epinephrine; RN given refers to iodidestructure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3082487
MeSH IDM0114431

Synonyms (8)

Synonym
nsc62513
38522-73-5
nsc-62513
nsc 62513
benzeneethanaminium, beta,3,4-trihydroxy-n,n,n-trimethyl-, iodide
n,n-dimethylepinephrine
catecholine
[2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]-trimethylazanium;iodide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (5)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Sodium-dependent dopamine transporterRattus norvegicus (Norway rat)IC50 (µMol)949.00000.00070.97749.7000AID169083
Sodium-dependent dopamine transporterRattus norvegicus (Norway rat)Ki530.00000.00030.37088.1600AID65655
Sodium- and chloride-dependent creatine transporter 1Rattus norvegicus (Norway rat)IC50 (µMol)221.00001.60001.60001.6000AID219566
Sodium-dependent serotonin transporterRattus norvegicus (Norway rat)IC50 (µMol)3,600.00000.00030.81978.4900AID3172
Sodium-dependent serotonin transporterRattus norvegicus (Norway rat)Ki390.00000.00000.705610.0000AID3173
Choline O-acetyltransferase Rattus norvegicus (Norway rat)Ki25,000.00000.00020.00130.0030AID52114
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Sodium-dependent serotonin transporterRattus norvegicus (Norway rat)Km150.00000.20000.20000.2000AID3174
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (13)

Assay IDTitleYearJournalArticle
AID169083Inhibition of high affinity dopamine uptake at concentration of 1 uM1993Journal of medicinal chemistry, Jun-25, Volume: 36, Issue:13
Inhibition and inactivation of presynaptic cholinergic markers using redox-reactive choline analogs.
AID218791Maximum rate was determined for high affinity transport of dopamine1993Journal of medicinal chemistry, Jun-25, Volume: 36, Issue:13
Inhibition and inactivation of presynaptic cholinergic markers using redox-reactive choline analogs.
AID65655Inhibition constant of high-affinity dopamine uptake1993Journal of medicinal chemistry, Jun-25, Volume: 36, Issue:13
Inhibition and inactivation of presynaptic cholinergic markers using redox-reactive choline analogs.
AID219697Maximum rate was determined for high affinity transport of choline1993Journal of medicinal chemistry, Jun-25, Volume: 36, Issue:13
Inhibition and inactivation of presynaptic cholinergic markers using redox-reactive choline analogs.
AID3174Michaelis-Menten constant was reported for high affinity transport of 5-HT1993Journal of medicinal chemistry, Jun-25, Volume: 36, Issue:13
Inhibition and inactivation of presynaptic cholinergic markers using redox-reactive choline analogs.
AID3175Maximum rate was determined for high affinity transport of 5-HT1993Journal of medicinal chemistry, Jun-25, Volume: 36, Issue:13
Inhibition and inactivation of presynaptic cholinergic markers using redox-reactive choline analogs.
AID52114Enzyme inhibition dissociation constant for choline acetyl transferase (ChAcT) was determined1993Journal of medicinal chemistry, Jun-25, Volume: 36, Issue:13
Inhibition and inactivation of presynaptic cholinergic markers using redox-reactive choline analogs.
AID169084Michaelis-Menten constant was reported for high affinity transport of dopamine1993Journal of medicinal chemistry, Jun-25, Volume: 36, Issue:13
Inhibition and inactivation of presynaptic cholinergic markers using redox-reactive choline analogs.
AID3173Inhibition constant of high-affinity 5-HT uptake1993Journal of medicinal chemistry, Jun-25, Volume: 36, Issue:13
Inhibition and inactivation of presynaptic cholinergic markers using redox-reactive choline analogs.
AID219696Michaelis-Menten constant was reported for high affinity transport of choline1993Journal of medicinal chemistry, Jun-25, Volume: 36, Issue:13
Inhibition and inactivation of presynaptic cholinergic markers using redox-reactive choline analogs.
AID3172Inhibition of high affinity 5-HT uptake at concentration of 1 uM1993Journal of medicinal chemistry, Jun-25, Volume: 36, Issue:13
Inhibition and inactivation of presynaptic cholinergic markers using redox-reactive choline analogs.
AID219566Inhibition of high affinity choline uptake at concentration of 1 uM1993Journal of medicinal chemistry, Jun-25, Volume: 36, Issue:13
Inhibition and inactivation of presynaptic cholinergic markers using redox-reactive choline analogs.
AID219695Inhibition constant of high-affinity choline uptake1993Journal of medicinal chemistry, Jun-25, Volume: 36, Issue:13
Inhibition and inactivation of presynaptic cholinergic markers using redox-reactive choline analogs.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (25.00)18.7374
1990's3 (37.50)18.2507
2000's3 (37.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.15 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (12.50%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]